224 related articles for article (PubMed ID: 34333108)
1. Bone marrow-derived mesenchymal stem cells transplantation ameliorates renal injury through anti-fibrotic and anti-inflammatory effects in chronic experimental renovascular disease.
Almeida A; Lira R; Oliveira M; Martins M; Azevedo Y; Silva KR; Carvalho S; Cortez E; Stumbo AC; Carvalho L; Thole A
Biomed J; 2022 Aug; 45(4):629-641. PubMed ID: 34333108
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of bone marrow-derived MSCs improves renal function and Na
Lira R; Oliveira M; Martins M; Silva C; Carvalho S; Stumbo AC; Cortez E; Verdoorn K; Einicker-Lamas M; Thole A; de Carvalho L
Cell Tissue Res; 2017 Aug; 369(2):287-301. PubMed ID: 28374150
[TBL] [Abstract][Full Text] [Related]
3. Correlations Between Interleukin-11 Expression and Hypertensive Kidney Injury in a Rat Model of Renovascular Hypertension.
Menendez-Castro C; Cordasic N; Dambietz T; Veelken R; Amann K; Hartner A; Hilgers KF
Am J Hypertens; 2020 Apr; 33(4):331-340. PubMed ID: 31840157
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells (MSC) prevented the progression of renovascular hypertension, improved renal function and architecture.
Oliveira-Sales EB; Maquigussa E; Semedo P; Pereira LG; Ferreira VM; Câmara NO; Bergamaschi CT; Campos RR; Boim MA
PLoS One; 2013; 8(11):e78464. PubMed ID: 24223811
[TBL] [Abstract][Full Text] [Related]
5. Chronic cyclooxygenase-2 inhibition does not alter blood pressure and kidney function in renovascular hypertensive rats.
Richter CM; Godes M; Wagner C; Maser-Gluth C; Herzfeld S; Dorn M; Priem F; Slowinski T; Bauer C; Schneider W; Neumayer HH; Kurtz A; Hocher B
J Hypertens; 2004 Jan; 22(1):191-8. PubMed ID: 15106811
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of hypertension and renal damage in renovascular hypertensive rats by iron restriction.
Oboshi M; Naito Y; Sawada H; Iwasaku T; Okuhara Y; Eguchi A; Hirotani S; Mano T; Tsujino T; Masuyama T
Hypertens Res; 2016 Dec; 39(12):832-839. PubMed ID: 27439494
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells protect against obstruction-induced renal fibrosis by decreasing STAT3 activation and STAT3-dependent MMP-9 production.
Matsui F; Babitz SK; Rhee A; Hile KL; Zhang H; Meldrum KK
Am J Physiol Renal Physiol; 2017 Jan; 312(1):F25-F32. PubMed ID: 27760767
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine-dependent cardiac remodeling and endothelial-myocyte coupling in a 2 kidney, 1 clip Goldblatt hypertension mouse model.
Tyagi N; Moshal KS; Lominadze D; Ovechkin AV; Tyagi SC
Can J Physiol Pharmacol; 2005 Jul; 83(7):583-94. PubMed ID: 16091784
[TBL] [Abstract][Full Text] [Related]
9. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension.
Ceron CS; Rizzi E; Guimaraes DA; Martins-Oliveira A; Cau SB; Ramos J; Gerlach RF; Tanus-Santos JE
Matrix Biol; 2012 May; 31(4):261-70. PubMed ID: 22342460
[TBL] [Abstract][Full Text] [Related]
10. Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice.
Li Y; Chakraborty A; Broughton BRS; Ferens D; Widdop RE; Ricardo SD; Samuel CS
Biomed Pharmacother; 2021 Dec; 144():112256. PubMed ID: 34607108
[TBL] [Abstract][Full Text] [Related]
11. Clinically Relevant Mesenchymal Stem/Stromal Cell Sheet Transplantation Method for Kidney Disease.
Oka M; Kameishi S; Cho YK; Song SU; Grainger DW; Okano T
Tissue Eng Part C Methods; 2023 Feb; 29(2):54-62. PubMed ID: 36719774
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction.
Mias C; Lairez O; Trouche E; Roncalli J; Calise D; Seguelas MH; Ordener C; Piercecchi-Marti MD; Auge N; Salvayre AN; Bourin P; Parini A; Cussac D
Stem Cells; 2009 Nov; 27(11):2734-43. PubMed ID: 19591227
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension.
Guimarães DA; Rizzi E; Ceron CS; Martins-Oliveira A; Gerlach RF; Shiva S; Tanus-Santos JE
Redox Biol; 2015 Dec; 6():386-395. PubMed ID: 26343345
[TBL] [Abstract][Full Text] [Related]
14. Bone Marrow-Derived Mesenchymal Stem Cells and Their Conditioned Medium Attenuate Fibrosis in an Irreversible Model of Unilateral Ureteral Obstruction.
da Silva AF; Silva K; Reis LA; Teixeira VP; Schor N
Cell Transplant; 2015; 24(12):2657-66. PubMed ID: 25695732
[TBL] [Abstract][Full Text] [Related]
15. Renal sympathetic denervation attenuates hypertension and vascular remodeling in renovascular hypertensive rats.
Li P; Huang PP; Yang Y; Liu C; Lu Y; Wang F; Sun W; Kong XQ
J Appl Physiol (1985); 2017 Jan; 122(1):121-129. PubMed ID: 27742806
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy.
Huuskes BM; Wise AF; Cox AJ; Lim EX; Payne NL; Kelly DJ; Samuel CS; Ricardo SD
FASEB J; 2015 Feb; 29(2):540-53. PubMed ID: 25395452
[TBL] [Abstract][Full Text] [Related]
17. Effects of telmisartan and linagliptin when used in combination on blood pressure and oxidative stress in rats with 2-kidney-1-clip hypertension.
Chaykovska L; Alter ML; von Websky K; Hohmann M; Tsuprykov O; Reichetzeder C; Kutil B; Kraft R; Klein T; Hocher B
J Hypertens; 2013 Nov; 31(11):2290-8; discussion 2299. PubMed ID: 24077249
[TBL] [Abstract][Full Text] [Related]
18. Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation.
Chang JW; Tsai HL; Chen CW; Yang HW; Yang AH; Yang LY; Wang PS; Ng YY; Lin TL; Lee OK
J Cell Mol Med; 2012 Dec; 16(12):2935-49. PubMed ID: 22862802
[TBL] [Abstract][Full Text] [Related]
19. [Expression and role of soluble epoxide hydrolase in renal tissue of two kidneys one clip hypertension rats model].
Pan YJ; Tao ZF; Wang Q; Lu M; Guan YF; Zhu Y; Wang Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 43(6):820-6. PubMed ID: 22178827
[TBL] [Abstract][Full Text] [Related]
20. The nonpeptide ANG-(1-7) mimic AVE 0991 attenuates cardiac remodeling and improves baroreflex sensitivity in renovascular hypertensive rats.
Cunha TM; Lima WG; Silva ME; Souza Santos RA; Campagnole-Santos MJ; Alzamora AC
Life Sci; 2013 Mar; 92(4-5):266-75. PubMed ID: 23333828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
